Cite
MLA Citation
E. Volkmann et al.. “SAT0157 NINTEDANIB DOSE ADJUSTMENTS AND ADVERSE EVENTS IN PATIENTS WITH PROGRESSIVE AUTOIMMUNE DISEASE-RELATED INTERSTITIAL LUNG DISEASES IN THE INBUILD TRIAL.” Annals of the rheumatic diseases, vol. 79, n.d., p. 1019. http://access.bl.uk/ark:/81055/vdc_100144722137.0x00003d